Eli Lilly (NYSE: LLY) is part of this group. On Sept. 16, the drugmaker announced plans to build a $5 billion facility in Virginia. Here are two things investors should know.
2 Things Investors Should Know About Eli Lilly’s $5 Billion Investment to Improve Its Drug Production Capacity
view original post